Although lobular breast cancer is predominantly luminal (ER+, PR+), a small fraction may be basal (or triple negative: ER-, PR-, and HER-2−) or HER-2-like, not unlike its ductal counterpart. This evidence concerns the gene ERBB2 and breast cancer.